Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.04 per share
-
Shares outstanding
-
106,324,269
-
Total 13F shares
-
7,627,734
-
Share change
-
+7,627,734
-
Total reported value
-
$129,886,000
-
Price per share
-
$17.19
-
Number of holders
-
30
-
Value change
-
+$129,886,015
-
Number of buys
-
30
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) as of Q3 2014
As of 30 Sep 2014,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,627,734 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Redmile Group, LLC, JANUS CAPITAL MANAGEMENT LLC, JENNISON ASSOCIATES LLC, BVF INC/IL, DEERFIELD MANAGEMENT CO, BAKER BROS. ADVISORS LP, Clearbridge Investments, LLC, SABBY MANAGEMENT, LLC, and FRANKLIN RESOURCES INC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.